Harbin Sanlian: Announcement on using idle own funds for entrusted financial management
Securities code: 002900 Securities abbreviation: Harbin Sanlian Announcement number: 2025-058
Harbin Sanlian Pharmaceutical Co., Ltd.
Announcement on using idle self-owned funds for entrusted financial management
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete, and contains no false records, misleading statements or major omissions.
Harbin Sanlian Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") held the 25th meeting of the fourth board of directors and the 20th meeting of the fourth board of supervisors on September 22, 2025, and reviewed and approved the "Proposal on the Use of Idle Own Funds for Entrusted Financial Management". In order to better improve the use efficiency of idle own funds and achieve the preservation and appreciation of funds, according to the company's overall capital arrangement plan, it is planned to use no more than (inclusive) RMB 30,000 Ten thousand yuan of idle self-owned funds for entrusted financial management. The term of use shall be valid for one year from the date of review and approval by the board of directors. This quota can be used repeatedly within the usage period. The specific situation is now announced as follows:
1. Overview of investment situation
Investment purpose: Without affecting the company's normal operations and capital security, use part of the idle self-owned funds for entrusted financial management to improve the efficiency of the use of self-owned funds, rationally use idle self-owned funds to increase the company's income, better maintain and increase the value of the company's funds, and safeguard the interests of the company's shareholders.
Investment varieties: The company will strictly control risks in accordance with relevant regulations and select qualified professional financial institutions with good credit and financial status, no bad integrity records and strong profitability as trustees, including commercial banks, securities companies, fund companies, trust companies and other institutions. The company's entrusted wealth management funds are used to invest in financial instruments with higher credit ratings and better liquidity in my country's market, including but not limited to investment and wealth management products issued by banks, trusts, securities, funds, futures, insurance asset management institutions, financial asset investment companies, private equity fund managers and other professional wealth management institutions.
Investment amount: The company plans to use idle self-owned funds not exceeding (inclusive) RMB 300 million for entrusted financial management. During the validity period of the above quota, the funds can be used on a rolling basis, and the investment amount at any point in time during the validity period of the quota (including the amount related to reinvestment of the income from the aforementioned investment) does not exceed the authorized limit.
Source of funds: The funds used by the company for entrusted financial management are idle self-owned funds and do not involve the use of raised funds or bank credit funds. The sources of funds are legal and compliant.
Authorization validity period: The quota period is one year from the date of review and approval by the board of directors.
Implementation method: This matter must be reviewed and approved by the board of directors, which authorizes the company's legal representative to sign relevant documents within the specified limit, and the company's management is responsible for the specific implementation work.
The company’s entrusted financial management status within the cumulative 12 months:
Unit: 10,000 yuan
Actual order of withdrawal Product Subscription amount Maturity income
Trustee name Product name Value date Maturity date Principal amount No. Type (10,000 yuan) (10,000 yuan) (10,000 yuan) CITIC Bank Shares Win-Win Huixin Exchange Rate Linked
structural existence
1 Co., Ltd. Hal RMB structured deposit 2,000 2024-9-27 2024-10-28 2,000 4.08
Bin Branch Issue 05727
China CITIC Bank Co., Ltd. win-win Huixin exchange rate link
structural existence
2 Hal Co., Ltd. RMB structured deposit 2,000 2024-11-15 2024-12-17 2,000 3.95
Bin Branch Issue 06807
China CITIC Bank Co., Ltd. win-win Huixin exchange rate link
structural existence
3 Co., Ltd. Hal RMB structured deposit 3,000 2025-2-20 2025-3-24 3,000 5.92
Bin Branch Issue 08789
China CITIC Bank Co., Ltd. win-win smart credit exchange rate linkage
structural existence
4 Co., Ltd. Hal RMB structured deposit 4,000 2025-4-24 2025-5-26 4,000 7.19
Bin Branch, Issue A02618
China CITIC Bank
Hua Xia Wealth Management Cash No. 105 Cash Management
5 Co., Ltd. Hal 2,000 2025-5-29 Unexpired Class B (CITIC Corporate Exclusive) Class Financial Management
Hama Branch
China CITIC Bank Co., Ltd. win-win smart credit exchange rate linkage
structural existence
6 Hal Co., Ltd. RMB structured deposit 2,000 2025-7-11 2025-8-11 2,000 3.01
Bin Branch Phase A08871
2. Review procedure
According to the "Shenzhen Stock Exchange Self-Regulatory Guidelines for Listed Companies No. 7 - Transactions and Related Party Transactions" and the company's relevant regulations, the use of idle self-owned funds for entrusted financial management is within the decision-making authority of the company's board of directors, does not need to be submitted to the shareholders' meeting for review, and does not constitute a related transaction.
3. Investment risks and risk control measures
- Investment risks
The company will choose financial products with high security and good liquidity for entrusted financial management. However, the financial market is greatly affected by macroeconomic policies, and it cannot be ruled out that this investment will be affected by market fluctuations. At the same time, there are also risks of operational errors and monitoring by relevant staff.
- Investment risk control measures
(1) Product selection: The company will choose to purchase financial products with good liquidity and high security, and clarify the amount, term, investment type, rights, obligations and legal responsibilities of both parties, etc. of the investment product. When selecting counterparties, focus on selecting qualified professional financial institutions with high credit ratings, good financial status, no bad integrity records and strong profitability as trustees, including commercial banks, securities companies, fund companies, trust companies and other institutions. At the same time, risks will be controlled by diversifying investment targets.
(2) Risk tracking: The company's financial center will pay close attention to and track the progress of financial products, and promptly analyze the investment direction of financial products. Once it is discovered that there are risk factors that may affect the security of the company's funds, it will promptly take preservation measures to control investment risks.
(3) Daily supervision: The company's internal audit department is responsible for auditing and supervising the use and custody of funds in invested products in accordance with the company's system requirements, conducting regular comprehensive inspections of invested entrusted financial products, and reporting to the Audit Committee of the Board of Directors.
The company's independent directors and board of supervisors have the right to conduct regular or unscheduled inspections of its investment products, and can hire professional institutions to conduct audits when necessary.
(4) Information disclosure: The company will promptly disclose relevant information in accordance with the relevant regulations of the Shenzhen Stock Exchange.
4. Impact on the company
The company's use of idle self-owned funds for entrusted financial management is carried out on the premise of ensuring the company's current financial status is stable and ensuring the company's capital needs for normal operations. It does not affect the company's need for normal daily capital turnover and does not affect the normal development of the company's main business. Entrusted financial management is conducive to improving the efficiency of fund use, obtaining certain investment returns, and safeguarding the interests of the company and all shareholders.
5. Opinions of the Supervisory Board
After review, the Board of Supervisors believes that the company's use of idle own funds for entrusted financial management will not affect the company's daily capital turnover and the normal development of its main business, and will help improve the efficiency of the use of its own funds and create investment returns. Agree that the company will use idle self-owned funds for entrusted financial management this time.
6. Documents for reference
Resolution of the 25th meeting of the company’s fourth board of directors;
Resolution of the 20th meeting of the company’s fourth supervisory board.
Announcement is hereby made.
Board of Directors of Harbin Sanlian Pharmaceutical Co., Ltd.
September 22, 2025